- Home
- Publications
- Publication Search
- Publication Details
Title
Influenza vaccines: Past, present, and future
Authors
Keywords
-
Journal
REVIEWS IN MEDICAL VIROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-05
DOI
10.1002/rmv.2243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates
- (2021) Nicole Darricarrère et al. Science Translational Medicine
- Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
- (2020) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010–2018)
- (2020) Joe W. Cross et al. VACCINE
- Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study
- (2020) Olga Pleguezuelos et al. npj Vaccines
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection
- (2020) Yun-Hee Kim et al. VACCINE
- Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility
- (2019) Nicholas C. Wu et al. Cell Host & Microbe
- Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza
- (2019) Toshiki Sekiya et al. VACCINE
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Autoantibodies in Pandemrix®-induced narcolepsy: Nine candidate autoantigens fail the conformational autoantibody test
- (2019) Madeleine Wallenius et al. AUTOIMMUNITY
- Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood
- (2019) Béatrice Laupèze et al. VACCINE
- A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study
- (2019) Sung-Ching Pan et al. VACCINE
- Narcolepsy Associated with Pandemrix Vaccine
- (2018) Tomi Sarkanen et al. Current Neurology and Neuroscience Reports
- The WHO global influenza surveillance and response system (GISRS)-A future perspective
- (2018) Alan J Hay et al. Influenza and Other Respiratory Viruses
- 65 years of influenza surveillance by a World Health Organization-coordinated global network
- (2018) Thedi Ziegler et al. Influenza and Other Respiratory Viruses
- Adjuvanted influenza vaccines
- (2018) John S. Tregoning et al. Human Vaccines & Immunotherapeutics
- Immunology and efficacy of MF59-adjuvanted vaccines
- (2018) Eun-Ju Ko et al. Human Vaccines & Immunotherapeutics
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- The adjuvant GLA-AF enhances human intradermal vaccine responses
- (2018) Darrick Carter et al. Science Advances
- Safety and Immunogenicity of a Full-Dose Split-Virion Inactivated Quadrivalent Influenza Vaccine in Healthy Children 6 to 35 Months of Age
- (2018) Corwin A. Robertson et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The evolution of seasonal influenza viruses
- (2017) Velislava N. Petrova et al. NATURE REVIEWS MICROBIOLOGY
- Factors affecting immune responses to the influenza vaccine
- (2017) Maria R. Castrucci Human Vaccines & Immunotherapeutics
- Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
- (2017) Daniel Stadlbauer et al. mSphere
- A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
- (2016) Stéphane Pillet et al. CLINICAL IMMUNOLOGY
- Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses
- (2016) Lauren Parker et al. JOURNAL OF GENERAL VIROLOGY
- Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial
- (2016) Ivan Fan-Ngai Hung et al. LANCET INFECTIOUS DISEASES
- Design of nanomaterial based systems for novel vaccine development
- (2016) Liu Yang et al. Biomaterials Science
- A Phase I Randomized, Observer-Blind, Controlled, Dose Escalation Trial of the Safety and Tolerability of Two Intramuscular Doses of DPX-RSV(A), a Respiratory Syncytial Virus (RSV) Vaccine Containing RSV SH Antigen and a Novel Adjuvant DepoVax, or SH Antigen Co-administered With Aluminum Hydroxide, or Placebo to Healthy Adults ≥50–64 Years of Age
- (2016) Joanne Langley et al. Open Forum Infectious Diseases
- Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis
- (2016) Zhengfa Liao et al. PLoS One
- Epidemiological and Virological Characterization of Influenza B Virus Infections
- (2016) Sivan Sharabi et al. PLoS One
- Current and next generation influenza vaccines: Formulation and production strategies
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Safety, immunogenicity and infectivity of new live attenuated influenza vaccines
- (2015) Irina Isakova-Sivak et al. Expert Review of Vaccines
- Advances in the development of influenza virus vaccines
- (2015) Florian Krammer et al. NATURE REVIEWS DRUG DISCOVERY
- Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines
- (2015) Carlos A. DiazGranados et al. VACCINE
- Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines
- (2015) Ernest Milián et al. Biomed Research International
- The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells
- (2014) A. Seubert et al. JOURNAL OF IMMUNOLOGY
- Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
- (2014) Danuta M. Skowronski et al. PLoS One
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Pathways of Antigen Processing
- (2013) Janice S. Blum et al. Annual Review of Immunology
- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- The evolving history of influenza viruses and influenza vaccines
- (2013) Claude Hannoun Expert Review of Vaccines
- Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 Influenza a virus
- (2013) Heather A. Paich et al. Obesity
- The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
- (2013) M. Vono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly
- (2013) P.G. Van Buynder et al. VACCINE
- Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis
- (2013) E. Miller et al. BMJ-British Medical Journal
- New World Bats Harbor Diverse Influenza A Viruses
- (2013) Suxiang Tong et al. PLoS Pathogens
- Isolation of a Novel Swine Influenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human Influenza C Viruses
- (2013) Ben M. Hause et al. PLoS Pathogens
- CD4+T Cells: Differentiation and Functions
- (2012) Rishi Vishal Luckheeram et al. Clinical & Developmental Immunology
- Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
- (2012) Nathalie Garçon et al. Expert Review of Vaccines
- The history of MF59®adjuvant: a phoenix that arose from the ashes
- (2012) Derek T O’Hagan et al. Expert Review of Vaccines
- AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
- (2012) Hanna Nohynek et al. PLoS One
- Adjuvant solution for pandemic influenza vaccine production
- (2012) C. H. Clegg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
- (2012) Carrie Reed et al. VACCINE
- Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
- (2012) David N. Taylor et al. VACCINE
- Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
- (2012) David L. Gordon et al. VACCINE
- Influenza vaccine
- (2012) Ramesh Verma et al. Human Vaccines & Immunotherapeutics
- Fluzone®Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults
- (2011) Filippo Ansaldi et al. Expert Review of Vaccines
- Silica Crystals and Aluminum Salts Regulate the Production of Prostaglandin in Macrophages via NALP3 Inflammasome-Independent Mechanisms
- (2011) Etsushi Kuroda et al. IMMUNITY
- Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
- (2011) Harish Nair et al. LANCET
- Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59
- (2011) A. H. Ellebedy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico
- (2011) Constantino López-Macías et al. VACCINE
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
- (2011) Samuele Calabro et al. VACCINE
- A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems
- (2011) Alexander R. Precioso et al. VACCINE
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
- (2011) Sandra Morel et al. VACCINE
- Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
- (2011) Rebecca J. Cox et al. VACCINE
- Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses
- (2011) Paula A. Lanthier et al. VACCINE
- Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens
- (2011) L.R. Stanberry et al. VACCINE
- Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine
- (2010) David Onions et al. BIOLOGICALS
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Influenza A Virus Polymerase: Structural Insights into Replication and Host Adaptation Mechanisms
- (2010) Stéphane Boivin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Estimates of US influenza-associated deaths made using four different methods
- (2009) William W. Thompson et al. Influenza and Other Respiratory Viruses
- Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch
- (2009) Gregory M. Glenn et al. VACCINE
- Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans
- (2009) Robert B. Couch et al. VACCINE
- Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months
- (2009) James C. King et al. VACCINE
- The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity
- (2008) Luigi Franchi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment
- (2008) George S. Hui et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
- (2008) Mirjam Kool et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention
- (2008) Dayong Wu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- The Global Circulation of Seasonal Influenza A (H3N2) Viruses
- (2008) C. A. Russell et al. SCIENCE
- The biology of influenza viruses
- (2008) Nicole M. Bouvier et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now